Heterogeneity of Treatment Effect by Baseline Risk in a Trial of Balanced Crystalloids versus Saline.
作者信息
McKown Andrew C, Huerta Luis E, Rice Todd W, Semler Matthew W
机构信息
1 Vanderbilt University Medical Center Nashville, Tennessee.
出版信息
Am J Respir Crit Care Med. 2018 Sep 15;198(6):810-813. doi: 10.1164/rccm.201804-0680LE.
Abstract
摘要
相似文献
1
Heterogeneity of Treatment Effect by Baseline Risk in a Trial of Balanced Crystalloids versus Saline.在平衡晶体液与生理盐水试验中，治疗效果按基线风险的异质性
Am J Respir Crit Care Med. 2018 Sep 15;198(6):810-813. doi: 10.1164/rccm.201804-0680LE.
2
Balanced crystalloids versus normal saline for fluid resuscitation in critically ill patients: A systematic review and meta-analysis with trial sequential analysis.平衡晶体液与生理盐水在危重症患者液体复苏中的比较：系统评价和试验序贯分析。
Am J Emerg Med. 2019 Nov;37(11):2072-2078. doi: 10.1016/j.ajem.2019.02.045. Epub 2019 Mar 1.
3
Balanced Crystalloids Versus Saline for Perioperative Intravenous Fluid Administration in Children Undergoing Neurosurgery: A Randomized Clinical Trial.平衡晶体液与生理盐水用于神经外科手术患儿围手术期静脉输液：一项随机临床试验。
J Neurosurg Anesthesiol. 2019 Jan;31(1):30-35. doi: 10.1097/ANA.0000000000000515.
4
Normal saline versus a balanced crystalloid for goal-directed perioperative fluid therapy in major abdominal surgery: a double-blind randomised controlled study.生理盐水与平衡晶体液用于腹部大手术围术期目标导向液体治疗的双盲随机对照研究。
Br J Anaesth. 2018 Feb;120(2):274-283. doi: 10.1016/j.bja.2017.11.088. Epub 2017 Dec 2.
5
Balanced crystalloids versus saline in critically ill patients: The PRISMA study of a meta-analysis.危重症患者中平衡晶体液与生理盐水的比较：一项荟萃分析的 PRISMA 研究。
Medicine (Baltimore). 2021 Sep 24;100(38):e27203. doi: 10.1097/MD.0000000000027203.
6
Balanced Crystalloids versus Saline in Critically Ill Adults - A Systematic Review with Meta-Analysis.危重症成人中平衡晶体液与生理盐水的比较：系统评价与荟萃分析。
NEJM Evid. 2022 Feb;1(2):EVIDoa2100010. doi: 10.1056/EVIDoa2100010. Epub 2022 Jan 18.
7
Comparison of balanced crystalloids versus normal saline in patients with diabetic ketoacidosis: a meta-analysis of randomized controlled trials.平衡晶体液与生理盐水在糖尿病酮症酸中毒患者中的比较：一项随机对照试验的荟萃分析。
Front Endocrinol (Lausanne). 2024 May 21;15:1367916. doi: 10.3389/fendo.2024.1367916. eCollection 2024.
8
Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation : Prospective, randomized, controlled trial.肾移植患者中醋酸盐缓冲晶体输注液与0.9%生理盐水输注及血流动力学稳定性的比较：前瞻性、随机、对照试验
Wien Klin Wochenschr. 2017 Sep;129(17-18):598-604. doi: 10.1007/s00508-017-1180-4. Epub 2017 Mar 2.
9
Balanced Crystalloids versus Saline in the Intensive Care Unit. The SALT Randomized Trial.重症监护病房中平衡晶体液与生理盐水的比较。SALT随机试验。
Am J Respir Crit Care Med. 2017 May 15;195(10):1362-1372. doi: 10.1164/rccm.201607-1345OC.
10
Balanced Crystalloids Versus Normal Saline in Kidney Transplant Patients: An Updated Systematic Review, Meta-analysis, and Trial Sequential Analysis.平衡晶体液与生理盐水在肾移植患者中的应用：一项更新的系统评价、荟萃分析和试验序贯分析。
Anesth Analg. 2024 Jul 1;139(1):58-67. doi: 10.1213/ANE.0000000000006932. Epub 2024 Apr 5.
引用本文的文献
1
Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill.重症监护中基于证据的个性化医疗：一种用于量化和应用重症患者个体化治疗效果的框架。
Lancet Respir Med. 2025 Jun;13(6):556-568. doi: 10.1016/S2213-2600(25)00054-2. Epub 2025 Apr 15.
2
Toward Precision in Critical Care Research: Methods for Observational and Interventional Studies.迈向重症监护研究的精准化：观察性和干预性研究方法。
Crit Care Med. 2024 Sep 1;52(9):1439-1450. doi: 10.1097/CCM.0000000000006371. Epub 2024 Aug 15.
3
Conditional Treatment Effect Analysis of Two Infusion Rates for Fluid Challenges in Critically Ill Patients: A Secondary Analysis of Balanced Solution versus Saline in Intensive Care Study (BaSICS) Trial.两种输液速度对危重症患者液体挑战的条件治疗效果分析：平衡溶液与生理盐水在重症监护研究（BaSICS 试验）中的二次分析。
Ann Am Thorac Soc. 2023 Jun;20(6):872-879. doi: 10.1513/AnnalsATS.202211-946OC.
4
Personalization of renal replacement therapy initiation: a secondary analysis of the AKIKI and IDEAL-ICU trials.个体化肾脏替代治疗起始时机：AKIKI 和 IDEAL-ICU 试验的二次分析。
Crit Care. 2022 Mar 21;26(1):64. doi: 10.1186/s13054-022-03936-y.
5
Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome.2019冠状病毒病（COVID-19）：细胞因子风暴、高炎症表型与急性呼吸窘迫综合征
Genes Dis. 2020 Dec;7(4):520-527. doi: 10.1016/j.gendis.2020.06.009. Epub 2020 Jun 29.
6
Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care. NHLBI Working Group Report.确定成人肺部与重症监护领域的临床研究重点。美国国立心肺血液研究所工作组报告。
Am J Respir Crit Care Med. 2020 Aug 15;202(4):511-523. doi: 10.1164/rccm.201908-1595WS.
7
Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.危重症患者基线死亡率风险对治疗效果的异质性：三项最近的脓毒症和 ARDS 随机对照试验的再分析。
Crit Care. 2019 May 3;23(1):156. doi: 10.1186/s13054-019-2446-1.
8
Balanced Crystalloid Solutions.平衡晶体溶液。
Am J Respir Crit Care Med. 2019 Apr 15;199(8):952-960. doi: 10.1164/rccm.201809-1677CI.
9
Resuscitation fluids.复苏液。
Curr Opin Crit Care. 2018 Dec;24(6):512-518. doi: 10.1097/MCC.0000000000000551.
本文引用的文献
1
Balanced Crystalloids versus Saline in Critically Ill Adults.重症成年患者中平衡晶体液与生理盐水的比较
N Engl J Med. 2018 Mar 1;378(9):829-839. doi: 10.1056/NEJMoa1711584. Epub 2018 Feb 27.
2
Predicting Major Adverse Kidney Events among Critically Ill Adults Using the Electronic Health Record.利用电子健康记录预测危重症成人患者的重大不良肾脏事件
J Med Syst. 2017 Aug 31;41(10):156. doi: 10.1007/s10916-017-0806-4.
3
Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.治疗效果异质性对重症监护随机试验报告与分析的影响
Am J Respir Crit Care Med. 2015 Nov 1;192(9):1045-51. doi: 10.1164/rccm.201411-2125CP.
4
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology.急性肾损伤临床试验设计：来自 NIDDK 临床试验方法学研讨会的报告。
Clin J Am Soc Nephrol. 2012 May;7(5):844-50. doi: 10.2215/CJN.12791211. Epub 2012 Mar 22.
5
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.用于描述器官功能障碍/衰竭的序贯器官衰竭评估（SOFA）评分。代表欧洲重症监护医学学会脓毒症相关问题工作组。
Intensive Care Med. 1996 Jul;22(7):707-10. doi: 10.1007/BF01709751.
Zotero 插件